Page last updated: 2024-08-21

hexacosanoic acid and bezafibrate

hexacosanoic acid has been researched along with bezafibrate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dijkstra, IM; Engelen, M; Fourcade, S; Houten, SM; Kemp, S; Ofman, R; Poll-The, BT; Pujol, A; Sanders, RJ; Schackmann, MJ; Wanders, RJ	1

Other Studies

1 other study(ies) available for hexacosanoic acid and bezafibrate

Article	Year
Bezafibrate lowers very long-chain fatty acids in X-linked adrenoleukodystrophy fibroblasts by inhibiting fatty acid elongation. Journal of inherited metabolic disease, 2012, Volume: 35, Issue:6 Topics: Acetyltransferases; Adrenoleukodystrophy; Animals; ATP Binding Cassette Transporter, Subfamily D, Member 1; ATP-Binding Cassette Transporters; Bezafibrate; Cells, Cultured; Enzyme Inhibitors; Fatty Acid Elongases; Fatty Acids; Humans; Hypolipidemic Agents; Male; Mice; Mice, Transgenic; Microsomes, Liver; Oxidation-Reduction; Peroxisome Proliferator-Activated Receptors; Recombinant Proteins	2012

Article

Year

Bezafibrate lowers very long-chain fatty acids in X-linked adrenoleukodystrophy fibroblasts by inhibiting fatty acid elongation.

Journal of inherited metabolic disease, 2012, Volume: 35, Issue:6

Topics: Acetyltransferases; Adrenoleukodystrophy; Animals; ATP Binding Cassette Transporter, Subfamily D, Member 1; ATP-Binding Cassette Transporters; Bezafibrate; Cells, Cultured; Enzyme Inhibitors; Fatty Acid Elongases; Fatty Acids; Humans; Hypolipidemic Agents; Male; Mice; Mice, Transgenic; Microsomes, Liver; Oxidation-Reduction; Peroxisome Proliferator-Activated Receptors; Recombinant Proteins

2012